3.5 billion and is preparing for pivotal phase 3 trials for its lead products in the US and EU. Organization & culture: Novadip Biosciences employs 45 dedicated professionals, fostering a collaborative and innovative environment. Our teams are committed to advancing the standard of care in regenerative medicine, driven by scientific excellence and patient-focused values. Recent developments: Novadip recently received RMAT designation from the FDA for NVD-003, its regenerative treatment for congenital pseudarthrosis of the tibia. The company has also reported positive interim clinical data for NVDX3 in spine fusion and is preparing for phase 3 trials for NVD-003 in both the US and EU.", "areaServed": "Brabant Wallon", "knowsAbout": [ "Chief Financial Officer", "Clinical Research Scientist", "Regulatory Affairs Manager", "Quality Assurance Specialist", "Business Development Manager" ], "address": { "@type": "PostalAddress", "addressLocality": "Ottignies-Louvain-la-Neuve", "addressCountry": "Belgium", "postalCode": "1348", "streetAddress": "11 Rue Granbonpré" } }
Joobs

💡 50% of hires happen without a job posting·

logo

NOVADIP Biosciences S.A.

  • Mont-Saint-Guibert, BE
  • 51-200
    • Pharmaceutical/Biotech

💼 Jobs and roles in the company

This page combines real job openings published by the company and roles automatically detected from its public data, recruitment history, and industry signals.

Explore these opportunities to discover the company's key roles and apply spontaneously to make yourself known now. Learn more about AI transparency and ESCO → →

Search

There are no vacancies for the selected filters.

Related companies in Pharmaceutical/Biotech